222 related articles for article (PubMed ID: 35675569)
1. Designing Lactate Dehydrogenase-Mimicking SnSe Nanosheets To Reprogram Tumor-Associated Macrophages for Potentiation of Photothermal Immunotherapy.
Ling J; Chang Y; Yuan Z; Chen Q; He L; Chen T
ACS Appl Mater Interfaces; 2022 Jun; 14(24):27651-27665. PubMed ID: 35675569
[TBL] [Abstract][Full Text] [Related]
2. SnSe Nanosheets Mimic Lactate Dehydrogenase to Reverse Tumor Acid Microenvironment Metabolism for Enhancement of Tumor Therapy.
Wang H; Wang B; Jiang J; Wu Y; Song A; Wang X; Yao C; Dai H; Xu J; Zhang Y; Ma Q; Xu F; Li R; Wang C
Molecules; 2022 Dec; 27(23):. PubMed ID: 36500643
[TBL] [Abstract][Full Text] [Related]
3. Nanodrug regulates lactic acid metabolism to reprogram the immunosuppressive tumor microenvironment for enhanced cancer immunotherapy.
Tian LR; Lin MZ; Zhong HH; Cai YJ; Li B; Xiao ZC; Shuai XT
Biomater Sci; 2022 Jul; 10(14):3892-3900. PubMed ID: 35686599
[TBL] [Abstract][Full Text] [Related]
4. The role of glycolysis and lactate in the induction of tumor-associated macrophages immunosuppressive phenotype.
Zhang Y; Zhang X; Meng Y; Xu X; Zuo D
Int Immunopharmacol; 2022 Sep; 110():108994. PubMed ID: 35777265
[TBL] [Abstract][Full Text] [Related]
5. Unveiling the veil of lactate in tumor-associated macrophages: a successful strategy for immunometabolic therapy.
Tao H; Zhong X; Zeng A; Song L
Front Immunol; 2023; 14():1208870. PubMed ID: 37564659
[TBL] [Abstract][Full Text] [Related]
6. Repolarizing tumor-associated macrophages by layered double hydroxide-based deacidification agent for tumor chemodynamic therapy and immunotherapy.
Chen C; Zhang W; Lu SY; Wang J; Tan Y; Zhao S; Ouyang Y; Xu L; Zhou B; Yin X; Ran H; Liu H
Colloids Surf B Biointerfaces; 2023 Mar; 223():113157. PubMed ID: 36716658
[TBL] [Abstract][Full Text] [Related]
7. Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles.
Chong L; Jiang YW; Wang D; Chang P; Xu K; Li J
J Nanobiotechnology; 2023 Oct; 21(1):401. PubMed ID: 37907987
[TBL] [Abstract][Full Text] [Related]
8. Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors.
Kes MMG; Van den Bossche J; Griffioen AW; Huijbers EJM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188427. PubMed ID: 32961257
[TBL] [Abstract][Full Text] [Related]
9. Targeting tumor-associated macrophages for cancer immunotherapy.
Cao X; Lai SWT; Chen S; Wang S; Feng M
Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
[TBL] [Abstract][Full Text] [Related]
10. Engineered Bacterial Biomimetic Vesicles Reprogram Tumor-Associated Macrophages and Remodel Tumor Microenvironment to Promote Innate and Adaptive Antitumor Immune Responses.
Zheng P; He J; Fu Y; Yang Y; Li S; Duan B; Yang Y; Hu Y; Yang Z; Wang M; Liu Q; Zheng X; Hua L; Li W; Li D; Ding Y; Yang X; Bai H; Long Q; Huang W; Ma Y
ACS Nano; 2024 Mar; 18(9):6863-6886. PubMed ID: 38386537
[TBL] [Abstract][Full Text] [Related]
11. Targeting tumor-associated macrophages as an antitumor strategy.
Cheng N; Bai X; Shu Y; Ahmad O; Shen P
Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
[TBL] [Abstract][Full Text] [Related]
12. An Ex Vivo 3D Tumor Microenvironment-Mimicry Culture to Study TAM Modulation of Cancer Immunotherapy.
Li YR; Yu Y; Kramer A; Hon R; Wilson M; Brown J; Yang L
Cells; 2022 May; 11(9):. PubMed ID: 35563889
[TBL] [Abstract][Full Text] [Related]
13. Protein-Crowned Micelles for Targeted and Synergistic Tumor-Associated Macrophage Reprogramming to Enhance Cancer Treatment.
Sun JH; Liang X; Cai M; Yan L; Chen Z; Guo L; Jing L; Wang Y; Zhou D
Nano Lett; 2022 Jun; 22(11):4410-4420. PubMed ID: 35575719
[TBL] [Abstract][Full Text] [Related]
14. Lactate-Responsive Gene Editing to Synergistically Enhance Macrophage-Mediated Cancer Immunotherapy.
Li Y; Wei Y; Huang Y; Qin G; Zhao C; Ren J; Qu X
Small; 2023 Aug; 19(35):e2301519. PubMed ID: 37156740
[TBL] [Abstract][Full Text] [Related]
15. In situ Engineering of Tumor-Associated Macrophages via a Nanodrug-Delivering-Drug (β-Elemene@Stanene) Strategy for Enhanced Cancer Chemo-Immunotherapy.
Chen W; Li Y; Liu C; Kang Y; Qin D; Chen S; Zhou J; Liu HJ; Ferdows BE; Patel DN; Huang X; Koo S; Kong N; Ji X; Cao Y; Tao W; Xie T
Angew Chem Int Ed Engl; 2023 Oct; 62(41):e202308413. PubMed ID: 37380606
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy.
Cheruku S; Rao V; Pandey R; Rao Chamallamudi M; Velayutham R; Kumar N
Int Immunopharmacol; 2023 Mar; 116():109569. PubMed ID: 36773572
[TBL] [Abstract][Full Text] [Related]
17. Engineering Endogenous Tumor-Associated Macrophage-Targeted Biomimetic Nano-RBC to Reprogram Tumor Immunosuppressive Microenvironment for Enhanced Chemo-Immunotherapy.
Wang Y; Yu J; Luo Z; Shi Q; Liu G; Wu F; Wang Z; Huang Y; Zhou D
Adv Mater; 2021 Oct; 33(39):e2103497. PubMed ID: 34387375
[TBL] [Abstract][Full Text] [Related]
18. d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma.
Han S; Bao X; Zou Y; Wang L; Li Y; Yang L; Liao A; Zhang X; Jiang X; Liang D; Dai Y; Zheng QC; Yu Z; Guo J
Sci Adv; 2023 Jul; 9(29):eadg2697. PubMed ID: 37467325
[TBL] [Abstract][Full Text] [Related]
19. Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel.
Dai X; Meng J; Deng S; Zhang L; Wan C; Lu L; Huang J; Hu Y; Zhang Z; Li Y; Lovell JF; Wu G; Yang K; Jin H
Theranostics; 2020; 10(7):3049-3063. PubMed ID: 32194854
[TBL] [Abstract][Full Text] [Related]
20. The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment.
Li L; Tian Y
Biomed Pharmacother; 2023 May; 161():114504. PubMed ID: 37002579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]